Last 2,295 KRW
Change Today +5.00 / 0.22%
Volume 9.7K
096760 On Other Exchanges
Korea SE
As of 1:13 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

jw holdings corp (096760) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/14 - 3,281
52 Week Low
01/27/14 - 2,019
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JW HOLDINGS CORP (096760)

Related News

No related news articles were found.

jw holdings corp (096760) Related Businessweek News

No Related Businessweek News Found

jw holdings corp (096760) Details

JW Holdings Corporation, through its subsidiaries, supplies medicine and medical supplies. The company manufactures transfusion fluid; and medical appliances, such as digital X-rays, LED astral lamps, incubators, etc. It also exports finished products, such as antimicrobials, antifungal agents, anticancer agents, gastrointestinal agents, basic I.V. solutions, aminoacid solutions, triple chamber solutions, and lipid emulsions; and APIs, such as carbapenem antibiotics, cephalosporin antibiotics, antifungals, and R&D related products. In addition, the company produces and supplies various car accessories and industrial products. JW Holdings Corporation was founded in 1945 and is headquartered in Seoul, South Korea.

Founded in 1945

jw holdings corp (096760) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jw holdings corp (096760) Key Developments

JW Holdings Corporation, Annual General Meeting, Mar 21, 2014

JW Holdings Corporation, Annual General Meeting, Mar 21, 2014., at 11:00 Korea Standard Time. Location: Korea (Seocho) JW Tower L2 layer. Agenda: To consider the approval of the consolidated financial statements; to consider incorporation of some changes in; to consider the election of Directors; to consider the election of audit; to consider the approval of director remuneration; and to consider the approval of the remuneration.

Baxter International Inc. and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products

Baxter International Inc. and JW Holdings announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation of omega 3 lipids. With this collaboration, Baxter will complement its leading global parenteral nutrition portfolio, and provide global commercial capabilities and clinical development. Under the terms of the agreement, Baxter will have exclusive rights to co-develop and distribute the products globally, with the exception of Korea. The arrangement includes a $25 million up-front payment that will be recorded as a special pre-tax in-process research and development charge in the third quarter of 2013. Additionally, the agreement calls for payments totaling up to $10 million for the achievement of regulatory milestones, along with royalties on future product sales. The agreement remains in effect for 10 years following the first product launch outside of Korea. The companies will share equally in the development costs and global clinical trials and registrations. JW Holdings will manufacture the products in its Dangjin, Korea facility. Additionally, Baxter has specified rights to certain additional nutritional products that JW Holdings may develop or produce in the future.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
096760:KS 2,295.00 KRW +5.00

096760 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 096760.
View Industry Companies

Industry Analysis


Industry Average

Valuation 096760 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JW HOLDINGS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at